Trogenix (private company)
		See something wrong or missing? Let us know
	
Offices:Edinburgh
			
			
			Business model:B2B
			
			Trogenix is a British biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour - via the Odysseus platform, which harnesses Synthetic Super-Enhancers (SSEs) to distinguish cancer cell states from healthy ones and drive selective payload delivery.
					Investors:
					
						
							we tracked 10 investors
						
					
				
				
					You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
					Investments 112.83M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Trogenix
| Name | Criteria | |
|---|---|---|
|  | Ability Pharma 70% | 
 | 
|  | AbolerIS Pharma 70% | 
 | 
|  | Acesion Pharma 70% | 
 | 
|  | Aignostics 70% | 
 | 
|  | Atai Life Sciences 70% | 
 | 
|  | Beckley Psytech 70% | 
 | 
|  | Bigfinite 70% | 
 | 
|  | CatalYm 70% | 
 | 
|  | Citryll 70% | 
 | 
|  | Inbrain Neuroelectronics 70% | 
 | 
 Belgium
 Belgium Austria
 Austria Switzerland
 Switzerland Estonia
 Estonia Finland
 Finland Iceland
 Iceland Latvia
 Latvia Lithuania
 Lithuania Norway
 Norway Sweden
 Sweden Ireland
 Ireland Italy
 Italy Portugal
 Portugal